Evidence map›Paper›PMID 31238501›Full record

ArticleMicroorganisms2019

Survey of Biosynthetic Gene Clusters from Sequenced Myxobacteria Reveals Unexplored Biosynthetic Potential.

Katherine Gregory, Laura A Salvador, Shukria Akbar, Barbara I Adaikpoh, D Cole Stevens

Abstract read
In one paragraph

Article in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Comparative Genomic Analysis ofMicroorganisms · 2025
    Article
  6. Article
  7. MyxoPortal: a database of myxobacterial genomic features.Database : the journal of biological databases and curation · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Biosynthetic Potential ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Unveiling the genomic potential ofMicrobial genomics · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katherine GregoryDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. kcgregor@go.olemiss.edu.
Laura A SalvadorDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. lasalvad@go.olemiss.edu.
Shukria AkbarDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. sakbar@go.olemiss.edu.
Barbara I AdaikpohDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. biadaikp@go.olemiss.edu.
D Cole StevensDepartment of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. stevens@olemiss.edu.ORCID 0000-0001-6668-9419

Funding

Eukaryotic translation factor inhibitors as selective translation factor probes and anticancer therapeuticsR03CA219320 · NCI · UNIVERSITY OF MISSISSIPPI · PI STEVENS, DAVID COLE · 2018 to 2019
$146k
American Association of Colleges of Pharmacy New Investigator AwardNCI NIH HHS 1R03CA219320-01A1NCI NIH HHS R03 CA219320
6 · The paper itself

Abstract

Coinciding with the increase in sequenced bacteria, mining of bacterial genomes for biosynthetic gene clusters (BGCs) has become a critical component of natural product discovery. The order Myxococcales, a reputable source of biologically active secondary metabolites, spans three suborders which all include natural product producing representatives. Utilizing the BiG-SCAPE-CORASON platform to generate a sequence similarity network that contains 994 BGCs from 36 sequenced myxobacteria deposited in the antiSMASH database, a total of 843 BGCs with lower than 75% similarity scores to characterized clusters within the MIBiG database are presented. This survey provides the biosynthetic diversity of these BGCs and an assessment of the predicted chemical space yet to be discovered. Considering the mere snapshot of myxobacteria included in this analysis, these untapped BGCs exemplify the potential for natural product discovery from myxobacteria.

Indexed as

biosynthetic gene clustersmyxobacterianatural product discovery

Identifiers

PMID31238501
PMCPMC6616573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.